has tirzepatide been approved for weight loss clinical trial results is FDA-approved management, with trials showing average weight Benefits of Mounjaro Weight Loss

Last month (May 2025), Novo announced that the US Food and Drug Administration (FDA) accepted its new drug application (NDA) submission for an investigational once-daily oral formulation of Wegovy (semaglutide) for chronic weight management in adults living with obesity or overweight with one or more comorbid conditions and to reduce the risk of major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease

Connor cautions

While most semaglutide side effects are self-limiting and manageable, certain symptoms warrant prompt medical evaluation

Eckburg, P.B

As a result, a peptide influencing connective tissue signaling may plausibly affect some mechanisms while leaving others completely unchanged

Many researchers who think they need split dosing actually need better titration